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Introduction: Haemophilic ankle arthropathy is caused by recurrent spontaneous joint 
haemorrhaging and leads to pain, deformity and loss of function. In the presence of ad-
vanced articular deterioration, therapeutic options are confined to either arthroplasty or 
arthrodesis, the latter still being referred to as the procedure of choice. However, total 
ankle replacement (TAR) has recently gained acceptance as an alternative.
Aim: To investigate the mid- to long- term results of TAR in haemophilic ankle 
arthropathy.
Materials and Methods: Seventeen TARs in 14 male patients (mean age: 43 years 
[range, 27.4- 57.6]), implanted between 1998 and 2012, were retrospectively ana-
lysed. Implant survival was estimated using Kaplan- Meier analysis. Haemophilic/viral 
status, complications and revision surgeries were recorded. Follow- up assessment of 
12 TARs was performed 9.6 years (range, 3.3- 17.8) postoperatively, including clinical 
examination, pain and satisfaction scales, the American Orthopaedic Foot and Ankle 
Society (AOFAS) hindfoot score, and the SF- 36. Radiographic evaluation of pre- and 
follow- up radiographs was conducted.
Results: Estimated implant survival was 94% at 5, 85% at 10 and 70% at 15 years, re-
spectively. Three cases required revision surgery. At follow- up, 9.6 years (range, 3.3- 
17.8) postoperatively, the level of satisfaction was 76% (range, 50- 100) and of pain 
2/10 (range, 0- 6) on the VAS. Range of motion had increased significantly (P = .037). 
The SF- 36 summary scores were comparable to those of a matched standard popula-
tion. The AOFAS hindfoot score averaged 81 points (range, 73- 90). All radiographs 
revealed component loosening or periprosthetic radiolucency.
Conclusion: Total ankle replacement in the presence of advanced haemophilic 
 arthropathy is a viable treatment option with favourable mid- /long- term results, 
 maintaining mobility of the ankle joint.
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1  | INTRODUCTION
Haemophilia is a rare, congenital, haematological disease (approxi-
mately 1 in 30 000 live male births1) associated with recurrent spon-
taneous haemorrhaging. Approximately 70% of all bleeding events 
involve the joints,2 eventually causing haemophilic arthropathy. Knees 
elbows and ankles are most commonly affected. Symptoms comprise 
joint pain and deformity, paired with loss of function. While haemo-
philia A (lack of factor VIII) and B (lack of factor IX) are X- linked hered-
itary disorders only affecting male subjects, other factor deficiencies 
may result in the same cycle of progressive destruction of target joints. 
Affected persons usually require lifelong medical attention and intri-
cate treatment plans provided by a multidisciplinary team of special-
ized health care professionals. Early diagnosis, patient training and 
monitoring, as well as rigorous substitution of the deficient clotting 
factor, are of paramount importance to delay adverse effects such as 
haemophilic arthropathy.
Once severe joint deterioration has occurred, and symptoms are 
no longer manageable by means of non- operative treatment or joint 
preserving procedures, further therapeutic options are confined to ei-
ther prosthetic joint replacement or arthrodesis. With regard to the 
ankle joint, current literature still refers to arthrodesis as the proce-
dure of choice,3,4 offering pain relief and favourable functional out-
comes, with minimal rates of postoperative complications.5 However, 
more recently total ankle replacement (TAR) has gained acceptance 
as an alternative in this setting. An increasing number of publications 
provide evidence of its capacity to reduce pain significantly, while 
preserving ankle motion, thereby potentially reducing adjacent joint 
disease.6-8 As the development and successes of TAR for said condi-
tion are of recent nature, there is still a paucity of long- term outcome 
reports. The objective of this study was, therefore, to investigate the 
mid- to long- term clinical and radiographic results after TAR in patients 
with haemophilic ankle arthropathy.
2  | MATERIALS AND METHODS
2.1 | Patients
For the purpose of this observational study, we searched our institu-
tional database for all cases of haemophilic patients who underwent 
primary TAR between 1998 and 2012. Seventeen consecutive cases 
in 14 male patients (age: 43 [range, 27.4- 57.6 years]) were identified. 
All patients provided informed consent. Approval of the responsible 
ethics committee (Kantonale Ethikkommission Zürich) was obtained. 
To facilitate readability of this article, we will in the following refer to 
cases rather than patients.
As illustrated in Figure 1, pre- and perioperative demographic and 
disease- specific data, as well as implant survival, were analysed in all 
17 cases. Two cases were not available for a follow- up visit. However, 
revision- free implant survival was confirmed via telephone interview. 
Three ankles had undergone revision surgery, two of which revision 
TAR (rTAR) and one arthrodesis. Thus, with a mean follow- up of 9.6 
(range, 3.3- 17.8), 12 cases were seen for follow- up examination.
An overview of the study population, basic demographics and 
disease- specific data are presented in Table 1. Eleven patients 
(78.6%) were diagnosed with haemophilia A, 2 patients (14.3%) with 
haemophilia B and one patient (7.1%) with a congenital factor VII 
deficiency. Thirteen surgeries (76.5) were indicated in the setting of 
severe, 3 (17.6%) in the setting of moderate and one (5.9%) in the 
setting of mild haemophilia† .9 One patient was HIV positive (6.9%) 
and 13 were diagnosed with chronic hepatitis B and/or C prior to 
surgery (76.5%). The mean preoperative Pettersson score was 
7.8 ± 6.8 (range, 5- 10).
2.2 | Surgical intervention
During the course of the 15- year long observation period, 4 differ-
ent implants were used, 6 AGILITY (DePuy, Leeds, United Kingdom), 
6 HINTEGRA (Newdeal SA, Lyon, France), 3 STAR (Link, Hamburg, 
Germany) and 2 MOBILITY (DePuy). All surgeries were performed 
by the institution’s senior foot and ankle surgeon at the time (PV, 
NE, JS). In 11 cases, surgical lengthening of the Achilles tendon/
Gastrocnemius was carried out to accomplish a minimum of 10° of 
intraoperative ankle dorsiflexion. Once, an additional talonavicular ar-
throdesis, thrice, additional subtalar arthrodeses were necessary due 
to concomitant arthropathy of the respective joints. In one case, sup-
plemental medializing calcaneal osteotomy for correction of hindfoot 
alignment was carried out.
2.3 | Peri- /postoperative treatment
Perioperative factor replacement therapy was overseen by a senior 
consultant haematologist. Both a careful review of recent bleeding 
history and laboratory analyses including measurement of clotting 
†Classification complies with the International Society on Thrombosis and Haemostasis (ISTH) 
standard and is based on clotting factor activity: severe <1%, moderate 1%- 5%, mild 
6%- 40%.
F IGURE  1 Patient/case selection and analyses
1998-2012: 
17 TAR
(14 paents) 
12 TAR
(9 paents)
2 unable to aend 
follow-up visit
3 component removal
(2 rTAR, 1 arthrodesis)
preop data, 
complicaons
survival analysis
follow-up analysis
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factor activity and antibody screening were obtained. Based on 
these preoperative parameters, repeat measurements of factor 
activity, intraoperative blood loss and postoperative bleeding ten-
dency, individual treatment schemes for intravenous factor substi-
tution were implemented. A preoperative loading dose aiming for 
100% factor activity was followed by bolus injections in decreas-
ing frequency, keeping factor activity between 70% and 90% during 
the first 3 days, and above 50% until day 8. Patients were released 
from inpatient treatment only when systemic and local control 
of the haemorrhagic diathesis was obtained. The duration of this 
early postoperative phase necessitating close coagulation manage-
ment corresponds to the duration of hospitalization which counted 
14.6 ± 4.3 days (range, 8- 26).
All patients received basic postoperative wound and pain man-
agement. Those without additional osseous interventions were al-
lowed to start full weight bearing in a cast or VACO®ped (Oped AG, 
Cham, Switzerland) after few days of bed rest. As soon as super-
ficial wound healing was achieved, passive ankle mobilization was 
started to increase range of motion (ROM). Those with additional 
osseous procedures were immobilized in a non- weight- bearing cast 
for 6 weeks. All patients transitioned to full weight- bearing not later 
than 3 months postoperatively, depending on the healing process and 
level of pain.
2.4 | Clinical assessment
At the follow- up visit, patients underwent an interview and a de-
tailed physical examination conducted by a senior resident (FE) not 
involved in the surgical treatment. Subjective levels of satisfac-
tion (0%- 100%) and pain (0- 10, visual analogue scale [VAS]) were 
recorded. Postoperative ROM was measured with a goniometer 
along the lateral boarder of the leg and foot in suspension, and 
compared to preoperative ROM, which could be extracted from 
the patients’ files. The American Orthopaedic Foot and Ankle 
Society (AOFAS) hindfoot score10,11 and the SF- 36 (Medical 
Outcome Study 36- Item Short- Form Health Survey)12 were ob-
tained. The sample group’s SF- 36 summery scores for physical and 
mental health were calculated based on those of a gender- and 
Absolute 
(n/17)
Proportion 
(%) Mean SD Min Max
Unable to attend follow- up 
visit
2 11.8
Revisions with component 
removala
3 17.6
Time to revision (y) 7.5 4.9 2.2 10.8
Prosthetic survival 14 82.4
Follow- up (y) 9.3 4.9 2.2 17.8
Prosthetic survival and 
follow- up visit
12 70.6
Follow- up (y) 9.6 5.4 3.3 17.8
Gender All male
Age at surgery (y) 43.4 11.1 27.4 57.6
BMI (kg/m²) 24.7 4 17.7 30.4
Smokers 4 23.5
Haemophilia A 11 78.6
Haemophilia B 2 14.3
Factor VII deficiency 1 7.1
Severe haemophilia 13 76.5
Moderate haemophilia 3 17.6
Mild haemophilia 1 5.9
Factor substitution on 
demand
12 85.7
Factor substitution regularly 2 14.3
HIV positive 1 6.9
Chronic hepatitis B and/or C 13 76.5
Pettersson score 7.8 6.8 5 10
a1 × arthrodesis, 2 × revision TAR.
TABLE  1 Overview: demographic and 
disease- specific data of 17 total ankle 
replacements (TAR) in haemophilic patients
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age- matched reference group (German norm population 1998, 
male, age 51- 60).13 Patients’ ability to participate in working life 
and activities of daily living (ADL), as well as their need for ortho-
paedic aids (yes/no, type), was inquired.
2.5 | Radiographic assessment
All radiographs were obtained in a weight- bearing position. Radiological 
evaluation was performed by a board- certified radiologist specialized 
in musculoskeletal radiology. The preoperative severity of haemo-
philic arthropathy was graded employing the Pettersson score.14 As 
proposed by Lecomte15 and adopted by Mulcahy et al,16 postopera-
tive radiographs were examined regarding component position, com-
ponent loosening (subsidence, migration, angulation), periprosthetic 
lucency, periprosthetic fracture, polyethylene wear or fracture, soft 
tissue abnormality and progressive degenerative changes in adjacent 
joints. Component position was assessed on standard anteroposte-
rior ankle radiographs by measuring the angle between the midline 
of the tibial and the talar component. Angles between 3° varus and 3° 
valgus were considered unremarkable. Ankle positions exceeding this 
range were considered mal- aligned as they may result in component 
edge- loading/- wear, impingement, and/or excessive unilateral foot 
pressure.15,17,18
2.6 | Statistical analysis
Statistical analysis was performed with IBM SPSS Statistics, Version 
21.0 (IBM Corp., Armonk, NY). Data are presented as mean, stand-
ard deviation (SD) and range for continuous variables and as propor-
tion (%) for categorical variables. The Kolmogorov- Smirnov test was 
applied to test for normality of distribution of data. Kaplan- Meier 
analysis with 95% confidence intervals (CI) was performed to estimate 
prosthetic survival. The Wilcoxon signed- rank test was used for test-
ing differences between means. A P- value of <.05 was considered to 
be statistically significant.
3  | RESULTS
3.1 | Implant survival
Implant survival was assessed for all 17 cases after a mean follow-
 up of 9.3 years (range, 2.2- 17.8). As a result of component loosen-
ing, 3 cases (17.6%) had undergone revision surgery with component 
removal (one arthrodesis, 2 rTAR) at a mean postoperative interval 
of 7.5 ± 4.9 years (range, 2.2- 10.8). Based on Kaplan- Meier curves, 
the estimated implant survival was 94% at 5, 85% at 10 and 70% at 
15 years. The mean estimated implant survival was 14.77 years (95% 
CI, 11.9- 17.7; Figure 2).
3.2 | Postoperative clinical outcome
A comprehensive synopsis of all clinical outcome parameters is of-
fered in Table 2. The levels of satisfaction and pain were 76 ± 11.8% 
(range, 50- 100) and 1.9/10 ± 2.0 (range, 0- 6) on the VAS, respectively. 
An increase in ROM was observed in 10 cases (83%) and a decrease 
in 2 cases (17%). Overall, ROM increased significantly (P = .037) by 
an	average	of	10.2	±	16.5°	 (range,	−30	to	32).	The	AOFAS	hindfoot	
score reached 81 ± 5.9 points (range, 73- 90). Regarding the SF- 36, 
the study population’s summery scores were 47 ± 13.0 (range, 16- 59) 
for physical and 57 ± 5.0 (range, 50- 65) for mental health. The corre-
sponding values for an age- and gender- matched norm population are 
47 and 52, respectively 19 (Table 3). All patients were able to pursue 
work and activities of daily living (ADL). Stair climbing was reported to 
be associated with no difficulties in one case, with minor difficulties in 
10 and major difficulties in one case. Engaging in sport activities was 
hardly possible. Except for orthopaedic footwear (3 × custom- made 
orthopaedic shoes; 1 × standard shoes with adjustments), no ortho-
paedic aids were needed.
3.3 | Radiographic assessment
A detailed case by case evaluation of all 12 ankles is presented in 
Table 4. Six prostheses were considered well- aligned (5 × 2°  valgus; 
0°) and 6 mal- aligned (4, 5, 10, 12, 13° valgus; 4° varus). All ra-
diographs displayed signs of component loosening: Subsidence was 
observed 5 times on the tibial side and 6 times on the talar side, 
component migration once on the tibial and 4 times on the talar side 
and angulation twice on the talar side. Periprosthetic radiolucency 
was present in 9 cases tibially and in 11 cases talarly. There were no 
periprosthetic fractures. Component wear or fracture as well as adja-
cent degenerative joint disease was rare. Subtalar degeneration was 
found in 3 cases. On the level of Chopart’s joint line, no degenerative 
changes were identified.
F I G U R E  2 Estimated implant survival based on Kaplan- Meier 
analysis
Prosthetic survivorship
year survival (%)
5 94
10 85
15 70
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3.4 | Complications
Peri- and postoperative complications are listed in Table 5. Two intra-
operative fractures, one of the lateral and one of the medial malleolus 
occurred, were immediately addressed with osteosynthesis. Neither 
the evaluation of the 2 patients’ files nor the assessment of their im-
agery was indicative of problems with fracture healing. However, both 
TABLE  2 Synopsis of individual clinical follow- up data of 12 cases of total ankle replacement in haemophilic patients with a follow- up of 
9.6 y
Case
Follow- up 
(y) Age (y)
Satisfaction 
(max. 100%)
VAS 
(max. 
10)
ROM (°)
AOFAS 
(max. 100)
SF- 36 summary 
scoresa
Pre Post Δ ROM
Gain (↑) loss 
(↓) n/12 [%]
Physical 
health
Mental 
health
1 6.8 54 75 6 25 20 −5 ↓ 73 47 50
2 4.2 60 70 0 10 25 15 ↑ 89 48 51
3 5.9 60 70 0 10 15 5 ↑ 89 48 51
4 13.4 62 75 3 5 15 10 ↑ 76 59 65
5 6.5 34 80 2 10 30 20 ↑ 80 56 60
6 6.9 34 80 2 20 30 10 ↑ 80 56 60
7 10.0 61 90 2 15 35 20 ↑ 76 16 57
8 17.0 53 60 0 5 10 5 ↑ 87 39 58
9 17.6 54 100 0 8 40 32 ↑ 83 49 59
10 17.8 54 100 0 15 45 30 ↑ 73 49 59
11 3.3 34 50 5 45 15 −30 ↓ 79 44 63
12 6.1 54 65 3 25 35 10 ↑ 90 49 56
Mean 9.6 51.1 76 1.9 16 26 10.2 10/12	(83)	↑ 81 47 57
SD 5.4 11.0 11.8 2.0 11.4 11.3 16.5 6.3 11.1 4.7
Min 3.3 34 50 0 5 10 −30 2/12	(17)	↓ 73 16 50
Max 17.8 62 100 6 45 45 32 90 59 65
P = .037b
Working/able to pursue activities 
of daily living Difficulties stairs Difficulties sports Orthopaedic aids
Yes Minor Major None
Yes Minor Major Custom- made shoes
Yes Minor Major Custom- made shoes
Yes Minor Impossible None
Yes Minor Major None
Yes Minor Major None
Yes Major Impossible Custom- made shoes
Yes None Impossible None
Yes Minor Minor None
Yes Minor Minor None
Yes Minor Major Adjusted shoes
Yes Minor Minor None
AOFAS, American Orthopaedic Foot and Ankle Society; ROM, range of motion.
aOn a scale from 0 to 100 points, the scores transmit the respondent’s subjective level of disability. 0 points correspond to full disability, 100 points to no 
disability.
bWilcoxon signed- rank test.
TABLE  3 SF- 36: study population vs standard populationa
Study 
population 
(male, Ø 51 y)
Standard 
population 
(male, 51- 60 y)
Summary score physical health 47 47
Summary score mental health 57 52
aGerman norm population 1998, male, age 51- 60.12
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patients were later revised secondary to prosthetic loosening, suggest-
ing a correlation between the intraoperative and the late complica-
tion. The patient with the medial malleolar fracture also sustained a 
lesion of the medial plantar nerve resulting in hypoesthesia and neu-
ropathic pain which was treated with benzodiazepines and pregaba-
lin. One postoperative haematoma spontaneously resolved during a 
prolonged hospital stay of 22 days. None of the patients developed 
wound- healing disorders, bleeding or infectious complications. In one 
case, a calcaneal and a first metatarsal stress fracture were diagnosed 
at the 4- month follow- up visit following onset of pain 2 weeks earlier. 
As symptoms had already subsided and the patient was unwilling to 
follow restrictions, no treatment was implemented. Two ankles under-
went soft tissue revision to improve ROM in the presence of sympto-
matic, reduced dorsiflexion. Three ankles underwent revision surgery 
with component removal, two of which rTAR and one arthrodesis. 
Both rTAR were performed due to symptomatic loosening of the talar 
component. In one case, only the talar component was exchanged 
(HINTEGRA Revision Ankle Prosthesis [Newdeal SA]), in the other the 
TAR was entirely replaced (SALTO TALARIS XT Revision TAR [Tornier, 
Inc., Bloomington, MN, USA]). The conversion to ankle fusion was 
achieved by anterior approach and plate osteosynthesis (INTEGRA 
TIBIAXYS Ankle Fusion [Newdeal SA]) with interposition of both au-
tologous cancellous bone harvested from the iliac crest and allograft.
4  | DISCUSSION
Haemophilic arthropathy is caused by recurrent spontaneous haemor-
rhaging and leads to articular deterioration. If symptoms are no longer 
manageable by means of non- operative treatment or joint preserving 
procedures, arthrodesis or prosthetic joint replacement needs to be 
considered. While arthrodesis has been known as the treatment of 
choice,20 TAR has recently been demonstrated to be a viable alterna-
tive with favourable short- and midterm outcome.6,7,21,22 However, 
data documenting the long- term outcome are sparse. Therefore, the 
aim of this study was to report the mid- to long- term results of TAR in 
patients with haemophilic arthropathy.
The estimated implant survival in this case series was 94% at 5, 
85% at 10 and 70% at 15 years. Corresponding studies reporting 
long- term outcomes in haemophiliacs are missing. However, the here 
reported long- term survival is comparable both to the results in pa-
tients with inflammatory joint disease 23 and to the results in a general 
population. As haemophilic arthropathy and inflammatory joint disease 
share some pathophysiological aspects,24 comparison seems particu-
larly applicable. In the light of this, the present study’s 15- year implant 
survival of 70% nearly accords with the 73% reported by Kraal et al23 
who examined 93 cases of TAR in inflammatory joint disease. Bartel 
et al25 reported 5- and 10- year survival rates of 87% and 81% (vs 94% 
and 85%), based on data of all 6 listed national joint registries including 
5152 primary TARs in general populations. Yet, 2 characteristics of hae-
mophilic patients set them apart. Firstly, microhaemorrhages around 
prosthetic components may cause destructive reactions leading to in-
creased rates of aseptic loosening.26 An example of such loosening is T
A
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illustrated in Figure 3. Secondly, patient age at time of surgery tends 
to be younger than in other populations leading to assumedly higher 
demands. It is still a matter of discussion though, to which degree pa-
tient age at time of TAR implantation affects prosthetic longevity.27-29
The clinical outcome of this study group was good, as represented 
by an AOFAS score which was situated at the upper end of the reported 
spectrum.7,21,30 However, while high levels of satisfaction, little pain and 
few restrictions regarding ADL were reported, all follow- up radiographs 
showed signs of either component loosening or periprosthetic lucency. 
Furthermore, half of the examined TAR was rated to be mal- aligned. 
These paradoxical clinical and radiographic findings may be partly at-
tributable to the concept of silent osteolysis which has been described 
in the context of joint replacement, rendering patients asymptomatic in 
spite of the presence of signs of component loosening.31,32 Moreover 
and along the lines of this present study, good clinical midterm results 
of TAR despite mild mal- alignment have been reported before.33
The average gain of ROM (10°) and the mean postoperative mo-
tion arc (26°) were satisfactory except during stair climbing, an action 
requiring dorsiflexion, above all. Thus, the importance of reaching and 
preserving a minimum of 10° during implantation and rehabilitation 
is highlighted.17 The question, whether or not preservation of ankle 
motion is beneficial in the long run, and when compared to fusion, 
remains unclear though. Remarkably, Stavrakis34 found that between 
8491 arthrodeses and 1280 ankle replacements, patients with TAR 
were less likely to need subsequent subtalar arthrodesis. The absence 
of symptomatic adjacent joint disease within our study group supports 
this hypothesis.
In discordance with previous publications using the SF- 36 for mea-
surement of health- related quality of life in patients with coagulation 
disorders,35,36 the perception of physical health in this population 
was equal to that of a designated reference group. Mental health was 
graded even superiorly. We hypothesize that the high level of subjec-
tive satisfaction stems from the comprehensive multidisciplinary care 
these patients receive from early on.
The incidence of mechanical complications (intraoperative/stress 
fracture, nerve lesion, unsatisfying ROM, component loosening) corre-
sponded to the literature.37,38 Malleolar fractures, for example, occur 
in up to 10% of during TAR implantation.39,40 Due to poor subchondral 
bone quality, the risk in haemophilic patients may be particularly high.
Notably, none of the patients developed bleeding complications. 
Furthermore, no revision surgeries for treatment of wound or peri-
prosthetic joint infection were necessary, although the diagnosis of 
haemophilia with concomitant hepatitides constitutes a known risk 
factor 41 and although the infection rate after TAR is documented to 
be 2%- 8.6%.42 Only few other studies discussing septic complications 
after TAR in haemophilic patients can are available for comparison. 
Strauss et al,21 with a series of 11 cases, reported 2 implant removals 
due to infection. Barg et al7 observed no infections in a series of 10.
This study has limitations. Firstly, this is a retrospective study. 
Also, due to incomplete preoperative scores, we were not able to 
longitudinally analyse all outcome parameters thereby missing out on 
potentially meaningful information. Secondly, while the majority of 
the study collective experienced an increase in ROM, we are aware 
that this gain may be related mostly to the reduction in pain and not 
necessarily to a mechanical advantage. Further concerning this matter, 
measurements were performed clinically using a goniometer, allowing 
for a certain inaccuracy due to both error in measurement and the un-
quantifiable degree of midfoot motion in combination with tibiotalar 
motion.43 Radiographic measurements were not performed. Thirdly, 
the AOFAS ankle/hindfoot score is a non- validated score.44 Despite 
these limitations, the presented results provide the longest follow- up 
of TAR in haemophilic patients, thereby expanding the scope of data 
and knowledge on this subject relevantly and serving future investiga-
tions as reference.
5  | CONCLUSION
Total ankle replacement in the setting of advanced haemophilic ankle 
arthropathy is a viable treatment option with favourable clinical mid- /
long- term results. Implant survival based on a 10- year follow- up 
is similar as in inflammatory joint disease and general populations. 
Preservation of ankle mobility appears to be advantageous in regard 
to patient comfort and occurrence of symptomatic adjacent joint dis-
ease. While clinical results are encouraging, follow- up radiographs 
reveal the presence of component loosening and periprosthetic radio-
lucency in the majority of cases. Bearing in mind the patient popula-
tion’s young age and specific risk factors, the need for revision surgery 
TABLE  5 Peri- /postoperative complications
Number Type Management Comment
2 Intraoperative fracture (1 × lateral, 1 × medial 
malleolus)
Osteosynthesis Both patients later underwent 
removal of TAR
1 Nerve lesion (medial plantar nerve) Medical treatment of neuropathic 
pain
Same patient suffered intraoperative 
fracture of medial malleolus
1 Haematoma Non- operative treatment
1 Stress fracture (calcaneus and first metatarsal) None Diagnosed retrospectively
2 Unsatisfying ROM, reduced dorsiflexion Soft tissue revision Both 11 mo postoperatively
3 Component loosening, associated with mechanical 
pain
Removal of TAR 2 rTAR (2.2/9.6 y postop), 1 
arthrodesis 10.8 y postop)
ROM, range of motion; TAR, total ankle replacement.
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resulting from symptomatic component loosening may arise in the 
long run. Further studies including a larger number of cases and even 
longer follow- up periods are warranted.
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